Brightview Holdings Inc
Change company Symbol lookup
Select an option...
BV Brightview Holdings Inc
PFE Pfizer Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
AEG Aegon NV
MGP MGM Growth Properties LLC
WRB W R Berkley Corp
ABBV Abbvie Inc
Go

Industrials : Commercial Services & Supplies | Small Cap Value
Company profile

Brightview Holdings Inc is a commercial landscaping services provider. The Company provides commercial landscaping services, ranging from landscape maintenance and enhancements to tree care and landscape development. It operates through an integrated national service prototype, which systematically delivers services at the local levels. The Company is a single-source end-to-end landscaping solution provider to diverse customer base at the national, regional and local levels. It operates through two segments: Maintenance Services and Development Services. Its maintenance services are primarily self-performed through its national branch network and are route-based in nature. Its development services are comprised of sophisticated design, coordination and installation of landscapes at some of the recognizable corporate, athletic and university complexes and showcase.

Closing Price
$17.46
Day's Change
-0.01 (-0.06%)
Bid
--
Ask
--
B/A Size
--
Day's High
17.65
Day's Low
17.37
Volume
(Average)
Volume:
159,940

10-day average volume:
162,429
159,940

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

9:00 am ET May 4, 2021 (BusinessWire) Print

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following investor conferences:

BofA Securities 2021 Health Care Conference Fireside Chat Presentation: Wednesday, May 12, 2021 at 2:45 p.m. Eastern Time

RBC Capital Markets Global Healthcare Conference Fireside Chat Presentation: Tuesday, May 18, 2021 at 3:05 p.m. Eastern Time

These conferences will be held virtually. Live webcasts of the presentations will be accessible on the company's website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson's disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005311/en/

SOURCE: Acadia Pharmaceuticals Inc.

Media Contact: 
Acadia Pharmaceuticals Inc.
Eric Endicott
(858) 914-7161
media@acadia-pharm.com

Investor Contact: 
Acadia Pharmaceuticals Inc.
Mark Johnson, CFA
(858) 261-2771
ir@acadia-pharm.com

 
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.